CVS Stock Analysis: Buy, Sell, or Hold?

CVS - CVS HEALTH CORPORATION

RETAIL-DRUG STORES AND PROPRIETARY STORES
$93.02
-0.63 (-0.67%) ▼
5d: -4.26%
30d: -12.98%
90d: -0.32%
HOLD
LOW Confidence
Protect Your CVS Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026 0d
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Aug 7, 2026 at $95.70 · last confirmed Aug 17, 2026

Strength: 6.1/10

Get Alerted When CVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: CVS is fairly valued with market pricing in 0.4% annual growth. Fine to hold or accumulate slowly on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$120.04
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$74.54
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CVS is currently trading at $93.02, which is considered oversold relative to its 30-day fair value range of $95.71 to $107.69. The stock's valuation (Forward PE: 10.9) is in line with its historical norms (10.8). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CVS is in a strong uptrend. The price is currently testing key support at $92.35. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: CVS scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $116.08 (+24.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $95.71 - $107.69
Company Quality Score 65/100 (BUY)
Volume Confirmation HIGH
Confidence Score 91.4%

Protect Your Profits

Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (80/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 24.8% below Wall St target ($116.08)
  • NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
  • CAUTION: Bottoming setup, but lagging the sector by 14% over 20 days — wait for relative strength

Trading Range Analysis

30-Day Trading Range $95.71 - $107.69
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $92.35
Resistance Level $97.51
Current Trend Strong Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.93
Wall Street Target $116.08 (+24.8%)
Revenue Growth (YoY) 7.1%
Earnings Growth (YoY) 188.8%
Profit Margin 1.2%
Valuation Premium vs History +0.4% premium
PE vs Historical 10.9 vs 10.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.4% (market-implied from PE analysis)
1-Year Target $93.39 (+0%)
2-Year Target $93.77 (+1%)
3-Year Target $94.14 (+1%)
3-Yr Target (if PE normalizes) (PE: 11→11) PE COMPRESSION $92.98 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: 7.0%) $209.26 (+125%)
Base: (SPY PE: 10.9, Growth: 7.0%) $114.01 (+23%)
Bear: (PE: 9.3, Growth: 7.0%) $96.91 (+4%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 24.71 | Current EPS (TTM): $3.79
Bull Case $206.03 (+122%)
Analyst growth 100.0%, PE expands to 27.2
Base Case $187.30 (+101%)
Market implied 100.0%, PE stable at 24.7
Bear Case $63.68 (-32%)
Severe decline -20.0%, PE contracts to 21.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 6:27 PM ET
Data refreshes hourly during market hours. Next update: 7:27 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CVS.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
UNH
UnitedHealth Group Incor…
STRONG BUY
27 analysts
$475 50 HOLD
CI
Cigna Corp
STRONG BUY
25 analysts
$341 48 HOLD
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$449 54 HOLD
HUM
Humana Inc
HOLD
26 analysts
$416 60 BUY
CNC
Centene Corp
BUY
19 analysts
$72 41 HOLD

Advanced CVS Option Strategies

Professional options setups generated by AI based on today's CVS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CVS

CVS Technical Chart CVS Price Prediction CVS Earnings Date CVS Investment Advisor CVS Fair Price Analyzer CVS Options Advisor CVS Options Chain CVS Options Analysis CVS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals